IDEAYA Biosciences, Inc. — Institutional Ownership
Which tracked institutions hold IDYA, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
24
Funds holding
$924477120
Total value held
Buying
21 added/new · 2 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $281291873 | 8442133 | +232741 | +2.84% |
| 2 | Janus Henderson Group Plc | $242023014 | 7265253 | — | NEW BUY |
| 3 | State Street Corp | $125988484 | 3781167 | -353474 | -8.55% |
| 4 | Goldman Sachs Group Inc | $63761719 | 1913617 | +142751 | +8.06% |
| 5 | Morgan Stanley | $61990332 | 1860453 | +608049 | +48.55% |
| 6 | Gsk Plc | $44426656 | 1333333 | — | NEW BUY |
| 7 | Bank Of America Corp /De/ | $31390473 | 942091 | +39118 | +4.33% |
| 8 | Northern Trust Corp | $24460911 | 734121 | +58998 | +8.74% |
| 9 | Wells Fargo & Company/Mn | $8854863 | 256144 | +13136 | +5.41% |
| 10 | Bank Of New York Mellon Corp | $8340824 | 250325 | +6284 | +2.57% |
| 11 | Invesco Ltd. | $8238515 | 238314 | +114118 | +91.89% |
| 12 | Franklin Resources Inc | $7672529 | 230268 | -9941 | -4.14% |
| 13 | Royal Bank Of Canada | $5392000 | 161837 | — | NEW BUY |
| 14 | Citigroup Inc | $4392706 | 127067 | +86260 | +211.39% |
| 15 | Sei Investments Co | $2824566 | 84760 | — | NEW BUY |
| 16 | Ameriprise Financial Inc | $1508164 | 45263 | +309 | +0.69% |
| 17 | Prudential Financial Inc | $581934 | 17465 | — | NEW BUY |
| 18 | Barclays Plc | $532453 | 15980 | — | NEW BUY |
| 19 | Marex Group Plc | $483173 | 14501 | — | NEW BUY |
| 20 | Pnc Financial Services Group, Inc. | $126715 | 3803 | +299 | +8.53% |
| 21 | Fifth Third Bancorp | $84279 | 2530 | — | NEW BUY |
| 22 | Us Bancorp \De\ | $83233 | 2498 | +55 | +2.25% |
| 23 | Atlantic Union Bankshares Corp | $27656 | 800 | — | Held |
| 24 | Amalgamated Financial Corp. | $48 | 4278 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.